Landmark Alliance ATOMIC Trial establishes new standard of care for patients with stage III dMMR colon cancer - EurekAlert!
Alliance presents results from phase III ATOMIC trial combining atezolizumab with chemotherapy for patients with stage III dMMR colon cancer at ASCO 2025 - EurekAlert!
